Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An Optimized Ultra-Low-Dose Imaging Protocol for Endovascular Aortic Repair Significantly Reduces Radiation and Contrast Exposures.

Journal of clinical medicine·2026
Same author

Mid-Term Outcomes of PTFE-Based Contralateral Iliac Limbs in Polyester-Based Fenestrated Bifurcated Endografts.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2026
Same author

Impact of cardiac phase selection on computational fluid dynamics analysis.

Journal of cardiovascular computed tomography·2025
Same author

Robustness and classification capabilities of MRI radiomic features in identifying carotid plaque vulnerability.

The British journal of radiology·2024
Same author

Editorial: Cerebrovascular imaging-From micro- to macroscopic scales.

Frontiers in neuroscience·2022
Same author

Estimation of the zero-pressure computational start shape of atherosclerotic plaques: Improving the backward displacement method with deformation gradient tensor.

Journal of biomechanics·2021

Related Experiment Videos

Contrast-induced nephropathy: do statins offer protection?

Umar Sadat1

  • 1Cambridge Vascular Unit, Addenbrooke's Hospital, Cambridge, UK. sadat.umar@gmail.com

Current Opinion in Cardiology
|May 4, 2011
PubMed
Summary

Statins do not currently have definitive evidence for preventing contrast-induced nephropathy (CIN), a complication of radiological studies. Further research is needed, though high-dose statins may offer potential renal protection.

Related Experiment Videos

Area of Science:

  • Nephrology
  • Cardiology
  • Radiology

Background:

  • Contrast-induced nephropathy (CIN) is a significant complication following contrast media administration in radiological procedures.
  • Statins are widely used for their antiatherosclerotic properties and are being investigated for potential nephroprotective effects.

Purpose of the Study:

  • To review clinical studies from 2010 investigating the role of statins in preventing contrast-induced nephropathy.
  • To synthesize current evidence regarding statin use for renal protection against CIN.

Main Methods:

  • Systematic review of clinical studies published in 2010.
  • Analysis of reported evidence on statin efficacy in preventing CIN.

Main Results:

  • Evidence regarding the specific use of statins for renal protection against CIN is conflicting and inconclusive.
  • No definitive evidence supports statin use solely for CIN prevention outside of their established antiatherosclerotic benefits.

Conclusions:

  • Current evidence is insufficient to recommend statins specifically for CIN prevention.
  • Large-scale, robust randomized controlled trials are necessary to establish efficacy.
  • Speculative benefits of high-dose statins for nephroprotection against CIN exist, drawing parallels with percutaneous coronary intervention protocols.